Quantcast
Last updated on April 16, 2014 at 13:10 EDT

Latest Sequenom Stories

2013-08-05 08:26:56

All Sequenom CMM Laboratory Locations CLIA-Certified and CAP-Accredited with Receipt of CAP Accreditation in North Carolina SAN DIEGO, Aug. 5, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that the New York Department of Health's Wadsworth Center Clinical Laboratory Evaluation Program (CLEP) has issued a clinical laboratory permit to allow the Sequenom Center for Molecular Medicine's...

2013-08-01 08:32:50

Companies to Join Forces to Broaden Market for Comprehensive Prenatal Analyses SAN DIEGO and IRVINE, Calif., Aug. 1, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, and CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics laboratory performing DNA-based testing services for developmental disorders and cancer, today jointly announced that the Sequenom Center for Molecular...

2013-07-24 16:24:30

Continued Growth in Testing Volumes as NIPT Market Leader SAN DIEGO, July 24, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $34.9 million for the second quarter of 2013, an increase of 91% compared to revenues of $18.3 million for the second quarter of 2012. Revenues from the Sequenom CMM diagnostics services operating segment were $24.5 million in the second quarter of...

2013-07-10 08:26:54

SAN DIEGO, July 10, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the second quarter of 2013 after closing of the NASDAQ Global Market on Wednesday, July 24, 2013. (Logo: http://photos.prnewswire.com/prnh/20040415/SQNMLOGO) A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior...

2013-06-12 08:27:38

SAN DIEGO, June 12, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that its wholly owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), has completed the build-out and validation of an additional laboratory location in Raleigh-Durham, NC, and is now processing patient samples commercially. This new laboratory location adds capacity and redundancy to the existing...

2013-05-30 08:28:24

SAN DIEGO and ST OUEN L'AUMONE, France, May 30, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it, along with its wholly owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), has entered into technology licensing and marketing agreements with Laboratoire Cerba in France for noninvasive prenatal aneuploidy testing. These agreements will expand access to Sequenom CMM's...

2013-05-28 08:27:50

SAN DIEGO, May 28, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Jefferies 2013 Global Healthcare Conference at the Grand Hyatt in New York, NY on June 3-6, 2013. Harry F. Hixson, Jr., Ph.D., Chairman and CEO, will present on Tuesday, June 4, 2013, beginning at 11:30 a.m. ET, to provide an overview of and update on the Company. The...

2013-05-19 23:01:48

Molecular Diagnostics Market research reports for US, UK, Spain, Japan, Italy, Germany and France are added to ReportsnReports.com stores. Dalla, TX (PRWEB) May 19, 2013 These molecular diagnostics market reports provide a comprehensive analysis for US, UK, Spain, Japan, Italy, Germany and France:     Major issues pertaining to the molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with...

2013-05-08 08:29:27

SAN DIEGO, May 8, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Bank of America Merrill Lynch Health Care Conference at the Encore at the Wynn Hotel in Las Vegas, NV on May 14-16, 2013. Paul V. Maier, Chief Financial Officer, will present on Thursday, May 16, 2013 beginning at 12:00 p.m. PDT, to provide an overview of and update on the...

2013-04-30 12:27:08

Industry Veteran to Lead Metamark Genetics in Commercialization of Novel Prognostic Tests for Prostate and Other Cancers CAMBRIDGE, Mass., April 30, 2013 /PRNewswire/ -- Metamark Genetics, Inc., a leader in the discovery of novel molecular prognostic and diagnostic tests for cancer, today announced that industry veteran Shawn M. Marcell has been named the company's new president and chief executive officer. Mr. Marcell succeeds interim executive Michael Kauffman, M.D., who will...